FDA Inspection 1216053 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 26, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on August 26, 2023, issued by the Center for Devices and Radiological Health, covering devices.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: August 26, 2023
Product Type: Devices
Office: Center for Devices and Radiological Health

Open in Dashboard

ID · 955ba795-ebdd-4ebb-861f-16909163e529

Violation Codes2

21 CFR 820.18621 CFR 820.70(g)

Full citation text and observation details available on the Dashboard.